Literature DB >> 6511668

Inhibition of fatty acid synthesis by the antibiotic thiolactomycin.

T Hayashi, O Yamamoto, H Sasaki, H Okazaki, A Kawaguchi.   

Abstract

The antibiotic thiolactomycin inhibits the growth of Escherichia coli K-12 and Pseudomonas aeruginosa 507 (beta-lactam supersensitive mutant). A micrograph of E. coli cells, which were grown at a sublethal concentration of thiolactomycin (20 micrograms/ml), revealed the morphological change with cell elongation. The effects of the antibiotic on syntheses of cellular constituents were studied by measuring the incorporation of labeled precursors into lipids and macromolecules. This antibiotic preferentially inhibited the incorporation of [14C]acetate into fatty acids and lipids. Addition of both palmitate and oleate, but not of either fatty acid alone, reversed the growth inhibition of P. aeruginosa by thiolactomycin. These findings support the conclusion that the effects of thiolactomycin are due to a specific inhibition of fatty acid synthetase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511668     DOI: 10.7164/antibiotics.37.1456

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  18 in total

Review 1.  The reductase steps of the type II fatty acid synthase as antimicrobial targets.

Authors:  Yong-Mei Zhang; Ying-Jie Lu; Charles O Rock
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

2.  Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12.

Authors:  J T Tsay; C O Rock; S Jackowski
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

3.  AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain.

Authors:  Jakub Pawelczyk; Anna Brzostek; Laurent Kremer; Bozena Dziadek; Anna Rumijowska-Galewicz; Marta Fiolka; Jaroslaw Dziadek
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

4.  In vivo and in vitro effects of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.

Authors:  K K Wallace; S Lobo; L Han; H A McArthur; K A Reynolds
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

5.  In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.

Authors:  N M Parrish; T Houston; P B Jones; C Townsend; J D Dick
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  A missense mutation in the fabB (beta-ketoacyl-acyl carrier protein synthase I) gene confers tiolactomycin resistance to Escherichia coli.

Authors:  Suzanne Jackowski; Yong-Mei Zhang; Allen C Price; Stephen W White; Charles O Rock
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 7.  Bacterial fatty acid metabolism in modern antibiotic discovery.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-23       Impact factor: 4.698

8.  Characterization of beta-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis.

Authors:  L Han; S Lobo; K A Reynolds
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

9.  Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis.

Authors:  Joanna C Betts; Alistair McLaren; Mark G Lennon; Fiona M Kelly; Pauline T Lukey; Steve J Blakemore; Ken Duncan
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Purification and characterization of [acyl-carrier-protein] acetyltransferase from Escherichia coli.

Authors:  P N Lowe; S Rhodes
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.